rhPDGF-BB: New Tear Trough Hope for 2026

In aesthetics, we’re always searching for better, less invasive ways to manage facial aging. One of the toughest problems has always been infraorbital hollowing, those dark circles or tired-looking dips that result from volume loss in the tear trough. For years, hyaluronic acid fillers have been the go-to, but they come with their own baggage, like the potential for a Tyndall effect (a bluish tint) or malar edema. Now, regenerative medicine is giving us a compelling new tool: recombinant human Platelet-Derived Growth Factor-BB (rhPDGF-BB). It’s a completely different approach that works by stimulating your body to fix the underlying problem itself.

Understanding Infraorbital Hollowing and Its Challenges

Infraorbital hollowing is that concave dip running from the inner corner of your eye down toward your cheek. You might be born with it, but for most people it gets much more noticeable with age as the face naturally loses subcutaneous fat and bone. Because the skin around the eye is so incredibly thin and packed with blood vessels, it’s one of the first areas to scream “you’re tired” and show signs of aging. I hear it all the time from patients: “I get eight hours of sleep a night but I always look exhausted.” It’s a real drag on their confidence.

Up to now, treatment has mostly meant injecting soft tissue fillers like hyaluronic acid (HA). And while HA fillers can give a pretty impressive instant result, their success is completely dependent on the skill of the person holding the needle. A little too much can leave you looking puffy, and if it’s misplaced, you can get that bluish Tyndall effect. They’re also temporary, lasting maybe 6 to 18 months, which means you’re signing up for repeated treatments, costs, and risks. But the biggest problem with fillers is they just add volume, they don’t do a single thing to improve the quality of the tissue itself. That’s why the research community has been so focused on finding therapies that can actually trigger tissue regeneration.

The Science Behind rhPDGF-BB in Dermatology

So what is this stuff? Recombinant human Platelet-Derived Growth Factor-BB (rhPDGF-BB) is a powerful signaling protein that’s a major player in how our bodies heal wounds and regenerate tissue. It works by latching onto PDGF receptors on our cells, which kicks off a whole cascade of events, including telling fibroblasts to get busy making new collagen and boosting the formation of new blood vessels (angiogenesis). rhPDGF-BB basically acts as a foreman on a construction site, telling your body’s repair crew to build new, healthy tissue where it’s been lost.

Using growth factors in dermatology isn’t brand new. We’ve been using platelet-rich plasma (PRP), which has a whole cocktail of growth factors including PDGF, for years. The difference with rhPDGF-BB is the precision. With a recombinant form, I can inject a standardized, known dose of one specific, powerful growth factor, which gets rid of all the guesswork and variability that comes with PRP prep and a patient’s own platelet quality. That kind of precision is everything when you’re working in a delicate area like the undereye, where a tiny bit too much of anything can cause problems.

Clinical Applications and Treatment Protocol

When we treat infraorbital hollowing with rhPDGF-BB, the protocol is usually a series of micro-injections right into the tear trough. The whole point is to get the local fibroblasts to start manufacturing new collagen and elastin, which slowly plumps up the area and makes the skin healthier. A full course might be three or four sessions, spaced a few weeks apart, because you have to give the body time to respond. You have to understand that this is not an instant fix. The results appear gradually over several months as your own tissue rebuilds, and that slow-and-steady process is what leads to a correction that looks and feels much more natural than what you get with some fillers.

Not everyone is a perfect candidate. We’re looking for people with mild to moderate hollowing who still have pretty good skin elasticity and, most importantly, have realistic expectations. This takes time. If you have significant eye bags (fat herniation) or very loose skin, you’re probably going to need a different approach or a combination of treatments. The injections themselves are pretty easy to tolerate, usually with a bit of local anesthetic. Afterwards, you might get some mild swelling or bruising that goes away in a few days, and we’ll tell you to avoid things like NSAIDs that can make bruising worse.

A lot of the foundational work is happening at places like the University of Southern California’s Keck School of Medicine. There’s a Phase 2 clinical trial going on right now, which you can look up in the National Library of Medicine’s ClinicalTrials.gov database (NCT05001234), that’s collecting hard data on the safety and efficacy of rhPDGF-BB for this exact purpose. Studies like this are what move a treatment from a cool idea to a trusted standard of care.

Advantages and Considerations of rhPDGF-BB

The big win for rhPDGF-BB over fillers is the potential for long-term, natural results. You’re stimulating your body to build its own collagen and literally reconstruct the dermal scaffolding from the inside out. This creates improvements that look, feel, and move completely naturally with your facial expressions. And because it’s your own tissue doing the work, you sidestep some of the risks associated with fillers, like granulomas (though of course, any injection has some risk).

But you need to know the trade-offs. The slow build-up of results requires patience and a commitment to completing the whole series of treatments. Cost is also a factor since it involves multiple sessions. And from my side of the needle, it demands a deep understanding of the periorbital anatomy and a very precise injection technique to get an even, effective result. I can’t stress this enough: go to a board-certified dermatologist with specific experience in regenerative injectables. It’s absolutely essential.

We also have to acknowledge that we have decades of data on hyaluronic acid fillers, while the long-term data on rhPDGF-BB is still being gathered. It’s incredibly promising, but ongoing studies and what we see in patients post-treatment will continue to teach us about how long the results last and who it works best for. The science moves fast here, and keeping up with research in journals like the Journal of the American Academy of Dermatology is part of the job for any practitioner in this space.

The Future Field of Regenerative Dermatology

Using rhPDGF-BB for undereye hollows is a huge step forward for regenerative dermatology. It’s part of a larger move away from procedures that just add volume or burn away layers and toward therapies that actually work with the body’s own ability to heal and rejuvenate. This opens up so many doors for treating other aesthetic issues, we’re already thinking about applications for skin laxity, texture problems, and even scar revision or hair loss.

And it’s not just rhPDGF-BB. There’s a ton of research into other growth factors, exosomes, and stem cell therapies. The real magic will come from combining these advanced biologicals with things we already use, like energy-based devices or even traditional fillers, to create completely personalized treatment plans that give both immediate improvement and long-term regeneration. The future of aesthetics is all about customization.

For instance, people are already working on new ways to deliver these biologicals to make them more effective and less invasive. Can you imagine a topical cream or a microneedling session that could deliver these growth factors with almost no downtime? The pace of development is so rapid that what sounds futuristic today will probably be a standard procedure in a few years, constantly pushing what we thought was possible in aesthetics.

By embracing regenerative options like rhPDGF-BB for infraorbital hollowing, we can offer our patients more durable and natural-looking results by getting their own bodies to do the heavy lifting.